US Stock MarketDetailed Quotes

Viking Therapeutics (VKTX)

Watchlist
  • 31.880
  • -2.460-7.16%
Close Jan 15 16:00 ET
  • 32.270
  • +0.390+1.22%
Pre 04:50 ET
3.60BMarket Cap-15.04P/E (TTM)

Viking Therapeutics (VKTX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-328.03%-94M
-65.05%-47.06M
-753.13%-52.33M
-19.64%-87.79M
-76.76%-31.18M
-11.72%-21.96M
-149.35%-28.51M
75.11%-6.13M
-51.61%-73.38M
-61.45%-17.64M
Net income from continuing operations
-264.02%-90.79M
-194.66%-65.56M
-66.80%-45.63M
-28.02%-109.96M
-43.94%-35.42M
-10.68%-24.94M
-15.73%-22.25M
-40.06%-27.36M
-24.73%-85.9M
-25.80%-24.61M
Operating gains losses
91.15%-10K
----
----
---112K
---1K
---113K
----
----
----
----
Depreciation and amortization
31.03%114K
49.33%112K
50.00%111K
18.49%346K
48.65%110K
19.18%87K
2.74%75K
2.78%74K
0.34%292K
2.78%74K
Other non cash items
-51.52%16K
18.52%32K
-8.11%34K
0.76%132K
-2.78%35K
175.00%33K
-37.21%27K
-7.50%37K
31.00%131K
80.00%36K
Change In working capital
-737.50%-8.64M
189.90%7.2M
-194.43%-15.06M
163.87%9.36M
-55.16%2.46M
-170.93%-1.03M
-259.62%-8.01M
289.80%15.95M
-65.18%3.55M
-15.48%5.48M
-Change in receivables
63.62%2.2M
92.99%-11K
277.10%2.47M
273.52%1.2M
-539.60%-646K
447.56%1.35M
-134.33%-157K
169.55%655K
-47.72%321K
-187.83%-101K
-Change in prepaid assets
-77.20%-4.83M
-6,341.77%-5.09M
-646.57%-9.55M
-93.04%446K
2,694.83%1.51M
-298.69%-2.73M
-101.07%-79K
177.41%1.75M
304.73%6.41M
95.95%-58K
-Change in payables and accrued expense
-1,422.02%-5.88M
261.75%12.43M
-157.56%-7.85M
386.49%8.12M
-69.86%1.73M
677.92%445K
-253.26%-7.69M
316.31%13.64M
-121.98%-2.83M
-27.38%5.72M
-Change in other current liabilities
-35.42%-130K
-44.44%-130K
-46.59%-129K
-15.85%-402K
-47.13%-128K
-10.34%-96K
-2.27%-90K
-3.53%-88K
-83.60%-347K
-3.57%-87K
Cash from discontinued investing activities
Operating cash flow
-328.03%-94M
-65.05%-47.06M
-753.13%-52.33M
-19.64%-87.79M
-76.76%-31.18M
-11.72%-21.96M
-149.35%-28.51M
75.11%-6.13M
-51.61%-73.38M
-61.45%-17.64M
Investing cash flow
Cash flow from continuing investing activities
517.83%160.03M
133.72%42.51M
113.76%63.25M
-208.99%-553.37M
-81.57%6.58M
306.65%25.9M
38.35%-126.06M
-21,018.65%-459.79M
-427.08%-179.09M
392.19%35.73M
Net investment purchase and sale
517.83%160.03M
133.72%42.51M
113.76%63.25M
-208.99%-553.37M
-81.57%6.58M
306.65%25.9M
38.35%-126.06M
-21,018.65%-459.79M
-427.08%-179.09M
392.19%35.73M
Cash from discontinued investing activities
Investing cash flow
517.83%160.03M
133.72%42.51M
113.76%63.25M
-208.99%-553.37M
-81.57%6.58M
306.65%25.9M
38.35%-126.06M
-21,018.65%-459.79M
-427.08%-179.09M
392.19%35.73M
Financing cash flow
Cash flow from continuing financing activities
-80.97%480K
-82.55%507K
-99.94%349K
125.69%612.46M
431.91%1M
3,508.11%2.52M
-98.91%2.91M
14,384.63%606.04M
6,418.76%271.38M
-98.25%188K
Net common stock issuance
--0
--0
--0
121.34%597.09M
-2,269.63%-46.66M
2,360.86%46.66M
-100.01%-25K
1,613,935.14%597.12M
4,057.17%269.76M
-6,053.13%-1.97M
Proceeds from stock option exercised by employees
-80.97%480K
-82.70%507K
-92.00%349K
59.77%10.81M
431.91%1M
252,300.00%2.52M
12.05%2.93M
9.96%4.36M
698.11%6.77M
25.33%188K
Net other financing activities
----
----
----
188.45%4.56M
2,269.63%46.66M
-2,269.63%-46.66M
--0
1,687.06%4.56M
-150.85%-5.15M
-81.48%1.97M
Cash from discontinued financing activities
Financing cash flow
-80.97%480K
-82.55%507K
-99.94%349K
125.69%612.46M
431.91%1M
3,508.11%2.52M
-98.91%2.91M
14,384.63%606.04M
6,418.76%271.38M
-98.25%188K
Net cash flow
Beginning cash position
-22.85%33.88M
-80.60%37.94M
-51.95%26.68M
51.55%55.52M
35.40%50.35M
-36.83%43.92M
965.13%195.58M
51.55%55.52M
38.91%36.63M
26.45%37.19M
Current changes in cash
929.28%66.5M
97.33%-4.05M
-91.96%11.26M
-251.70%-28.69M
-229.08%-23.6M
120.02%6.46M
-396.46%-151.67M
867.27%140.11M
79.81%18.91M
158.10%18.28M
Effect of exchange rate changes
79.31%-6K
-500.00%-12K
102.08%1K
-393.33%-148K
-248.00%-74K
57.35%-29K
200.00%3K
-433.33%-48K
88.37%-30K
-64.54%50K
End cash Position
99.37%100.38M
-22.85%33.88M
-80.60%37.94M
-51.95%26.68M
-51.95%26.68M
35.40%50.35M
-36.83%43.92M
965.13%195.58M
51.55%55.52M
51.55%55.52M
Free cash flow
-328.03%-94M
-65.05%-47.06M
-753.13%-52.33M
-19.64%-87.79M
-76.76%-31.18M
-11.72%-21.96M
-149.35%-28.51M
75.11%-6.13M
-51.61%-73.38M
-61.45%-17.64M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -328.03%-94M-65.05%-47.06M-753.13%-52.33M-19.64%-87.79M-76.76%-31.18M-11.72%-21.96M-149.35%-28.51M75.11%-6.13M-51.61%-73.38M-61.45%-17.64M
Net income from continuing operations -264.02%-90.79M-194.66%-65.56M-66.80%-45.63M-28.02%-109.96M-43.94%-35.42M-10.68%-24.94M-15.73%-22.25M-40.06%-27.36M-24.73%-85.9M-25.80%-24.61M
Operating gains losses 91.15%-10K-----------112K---1K---113K----------------
Depreciation and amortization 31.03%114K49.33%112K50.00%111K18.49%346K48.65%110K19.18%87K2.74%75K2.78%74K0.34%292K2.78%74K
Other non cash items -51.52%16K18.52%32K-8.11%34K0.76%132K-2.78%35K175.00%33K-37.21%27K-7.50%37K31.00%131K80.00%36K
Change In working capital -737.50%-8.64M189.90%7.2M-194.43%-15.06M163.87%9.36M-55.16%2.46M-170.93%-1.03M-259.62%-8.01M289.80%15.95M-65.18%3.55M-15.48%5.48M
-Change in receivables 63.62%2.2M92.99%-11K277.10%2.47M273.52%1.2M-539.60%-646K447.56%1.35M-134.33%-157K169.55%655K-47.72%321K-187.83%-101K
-Change in prepaid assets -77.20%-4.83M-6,341.77%-5.09M-646.57%-9.55M-93.04%446K2,694.83%1.51M-298.69%-2.73M-101.07%-79K177.41%1.75M304.73%6.41M95.95%-58K
-Change in payables and accrued expense -1,422.02%-5.88M261.75%12.43M-157.56%-7.85M386.49%8.12M-69.86%1.73M677.92%445K-253.26%-7.69M316.31%13.64M-121.98%-2.83M-27.38%5.72M
-Change in other current liabilities -35.42%-130K-44.44%-130K-46.59%-129K-15.85%-402K-47.13%-128K-10.34%-96K-2.27%-90K-3.53%-88K-83.60%-347K-3.57%-87K
Cash from discontinued investing activities
Operating cash flow -328.03%-94M-65.05%-47.06M-753.13%-52.33M-19.64%-87.79M-76.76%-31.18M-11.72%-21.96M-149.35%-28.51M75.11%-6.13M-51.61%-73.38M-61.45%-17.64M
Investing cash flow
Cash flow from continuing investing activities 517.83%160.03M133.72%42.51M113.76%63.25M-208.99%-553.37M-81.57%6.58M306.65%25.9M38.35%-126.06M-21,018.65%-459.79M-427.08%-179.09M392.19%35.73M
Net investment purchase and sale 517.83%160.03M133.72%42.51M113.76%63.25M-208.99%-553.37M-81.57%6.58M306.65%25.9M38.35%-126.06M-21,018.65%-459.79M-427.08%-179.09M392.19%35.73M
Cash from discontinued investing activities
Investing cash flow 517.83%160.03M133.72%42.51M113.76%63.25M-208.99%-553.37M-81.57%6.58M306.65%25.9M38.35%-126.06M-21,018.65%-459.79M-427.08%-179.09M392.19%35.73M
Financing cash flow
Cash flow from continuing financing activities -80.97%480K-82.55%507K-99.94%349K125.69%612.46M431.91%1M3,508.11%2.52M-98.91%2.91M14,384.63%606.04M6,418.76%271.38M-98.25%188K
Net common stock issuance --0--0--0121.34%597.09M-2,269.63%-46.66M2,360.86%46.66M-100.01%-25K1,613,935.14%597.12M4,057.17%269.76M-6,053.13%-1.97M
Proceeds from stock option exercised by employees -80.97%480K-82.70%507K-92.00%349K59.77%10.81M431.91%1M252,300.00%2.52M12.05%2.93M9.96%4.36M698.11%6.77M25.33%188K
Net other financing activities ------------188.45%4.56M2,269.63%46.66M-2,269.63%-46.66M--01,687.06%4.56M-150.85%-5.15M-81.48%1.97M
Cash from discontinued financing activities
Financing cash flow -80.97%480K-82.55%507K-99.94%349K125.69%612.46M431.91%1M3,508.11%2.52M-98.91%2.91M14,384.63%606.04M6,418.76%271.38M-98.25%188K
Net cash flow
Beginning cash position -22.85%33.88M-80.60%37.94M-51.95%26.68M51.55%55.52M35.40%50.35M-36.83%43.92M965.13%195.58M51.55%55.52M38.91%36.63M26.45%37.19M
Current changes in cash 929.28%66.5M97.33%-4.05M-91.96%11.26M-251.70%-28.69M-229.08%-23.6M120.02%6.46M-396.46%-151.67M867.27%140.11M79.81%18.91M158.10%18.28M
Effect of exchange rate changes 79.31%-6K-500.00%-12K102.08%1K-393.33%-148K-248.00%-74K57.35%-29K200.00%3K-433.33%-48K88.37%-30K-64.54%50K
End cash Position 99.37%100.38M-22.85%33.88M-80.60%37.94M-51.95%26.68M-51.95%26.68M35.40%50.35M-36.83%43.92M965.13%195.58M51.55%55.52M51.55%55.52M
Free cash flow -328.03%-94M-65.05%-47.06M-753.13%-52.33M-19.64%-87.79M-76.76%-31.18M-11.72%-21.96M-149.35%-28.51M75.11%-6.13M-51.61%-73.38M-61.45%-17.64M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More